Open AccessThe Safety and Effectiveness of Infliximab Biosimilar in Managing Rheumatoid Arthritis: A Real-Life Experience from Jordan
Author(s) -
Khaldoon Alawneh,
AbdelHameed AlMistarehi,
Ali Qandeel,
Ruba A. Jaber,
Safwan Alomari,
Khalid Kheirallah
Publication year - 2022
Publication title -
international journal of clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.756
H-Index - 98
eISSN - 1742-1241
pISSN - 1368-5031
DOI - 10.1155/2022/3406783
Subject(s) - medicine , biosimilar , discontinuation , infliximab , rheumatoid arthritis , adverse effect , erythrocyte sedimentation rate , cohort , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom